These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4153181)

  • 1. [Clinical experiences with a new beta-sympatholytic agent Kö 1366 (bunitrolol)].
    Wallnöfer H; Täuber K
    Wien Med Wochenschr; 1974 Sep; 124(38):550-7. PubMed ID: 4153181
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the influence of a beta-receptor blocking agent on plasma renin activity in man].
    Distler A; Abdelhamid S; Philippi A; Rahn KH
    Verh Dtsch Ges Inn Med; 1971; 77():937-9. PubMed ID: 4405363
    [No Abstract]   [Full Text] [Related]  

  • 3. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 4. [Review of literature and experimental contribution on KO 592, a drug with beta-adrenolytic activity. I].
    Marmo E; Caputi AP; Saini RK
    Clin Ter; 1972 Jul; 62(1):11-51. PubMed ID: 4403671
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness and limitations of adrenergic beta receptor blocking in the treatment of the stenocardia syndrome and of some disorders of cardiac rhythm: clinical trial with INPEA (N-isopropyl-p-mitrophenylethanolamine)].
    Piva M; Ongari R; Dotti F
    Clin Ter; 1968 Oct; 47(1):53-84. PubMed ID: 4393774
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with the new beta sympatholytic agent Dalzic (ICI 50 172)].
    Weber H
    Med Welt; 1973 May; 24(18):749-51. PubMed ID: 4145085
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxprenolol: clinical experiences with a new beta-adrenergic blocking drug.
    Bauer GE; Michell G
    Med J Aust; 1970 Jan; 1(4):170-3. PubMed ID: 4190852
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the treatment of angina pectoris with beta-blocking agents (Eraldin, Visken)].
    Mihail A; Popescu P; Ioan A; Bruckner I; Paraschiv A; Petrescu X; Popa N
    Med Interna (Bucur); 1973 Jan; 25(1):87-93. PubMed ID: 4144020
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of a pure beta-blockador, 1-(4-nitrophenyl)-2-isopropylamino-ethanol in angina pectoris].
    Gasparotto G; Pagnan A
    Folia Cardiol; 1969; 28():40-3. PubMed ID: 4397999
    [No Abstract]   [Full Text] [Related]  

  • 10. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of a new cardioselective beta-adrenergic blocker (tolamolol) on exercise tolerance in patients with angina pectoris.
    Sood NK; Havard CW
    Thorax; 1973 May; 28(3):331-4. PubMed ID: 4146782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic use of beta-receptor blocking agents].
    Wallnöfer H; Bereitter E
    Wien Klin Wochenschr; 1968 Apr; 80(15):288-92. PubMed ID: 5688615
    [No Abstract]   [Full Text] [Related]  

  • 13. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 14. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
    Musial W; Tracz W; Krzemińska-Pakula M
    Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new beta-receptor blockader as anti-arrhythmic agent].
    Dahlberg A
    Lakartidningen; 1972 Mar; 69(12):1334-5. PubMed ID: 4402107
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of beta sympatholytic agent ICI 50172 (Dalzic) in various cardiovascular diseases].
    Müller H; Barthels F; Kluthe R
    Med Klin; 1973 May; 68(19):634-41. PubMed ID: 4125216
    [No Abstract]   [Full Text] [Related]  

  • 17. [Eraldin: a cardioselective beta-adrenergic receptor blocking agent in the treatment of angina pectoris].
    Musial W; Krzemińska-Pakula M; Tracz W
    Pol Tyg Lek; 1971 Aug; 26(34):1316-8. PubMed ID: 4398697
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beta-adrenergic blockaders in cardiology].
    Muniz M
    Arq Bras Cardiol; 1979 Oct; 33(4):283-92. PubMed ID: 44836
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences with -receptor blockader Propranolol in the treatment of angina pectoris and tachycrdiac arrhythmias].
    Eisenreich R
    Z Arztl Fortbild (Jena); 1970 Jun; 64(11):529-34. PubMed ID: 4106268
    [No Abstract]   [Full Text] [Related]  

  • 20. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.